Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · IEX Real-Time Price · USD
0.680
-0.046 (-6.35%)
At close: Mar 28, 2024, 4:00 PM
0.713
+0.033 (4.87%)
After-hours: Mar 28, 2024, 6:53 PM EDT
Phio Pharmaceuticals Market Cap
Phio Pharmaceuticals has a market cap or net worth of $3.32 million as of March 28, 2024. Its market cap has decreased by -48.11% in one year.
Market Cap
3.32M
Enterprise Value
-5.07M
1-Year Change
-48.11%
Ranking
Category
Stock Price
$0.68
Market Cap Chart
Since May 10, 2012, Phio Pharmaceuticals's market cap has decreased from $18.50M to $3.32M, a decrease of -82.05%. That is a compound annual growth rate of -13.45%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 1.80M | - |
Mar 26, 2024 | 1.80M | -5.26% |
Mar 25, 2024 | 1.90M | 5.56% |
Mar 22, 2024 | 1.80M | -14.29% |
Mar 21, 2024 | 2.10M | -19.23% |
Mar 20, 2024 | 2.60M | 8.33% |
Mar 19, 2024 | 2.40M | - |
Mar 18, 2024 | 2.40M | 4.35% |
Mar 15, 2024 | 2.30M | - |
Mar 14, 2024 | 2.30M | -8.00% |
Mar 13, 2024 | 2.50M | 4.17% |
Mar 12, 2024 | 2.40M | -4.00% |
Mar 11, 2024 | 2.50M | 8.70% |
Mar 8, 2024 | 2.30M | 4.55% |
Mar 7, 2024 | 2.20M | - |
Mar 6, 2024 | 2.20M | 4.76% |
Mar 5, 2024 | 2.10M | -4.55% |
Mar 4, 2024 | 2.20M | -4.35% |
Mar 1, 2024 | 2.30M | -11.54% |
Feb 29, 2024 | 2.60M | 8.33% |
Feb 28, 2024 | 2.40M | 4.35% |
Feb 27, 2024 | 2.30M | - |
Feb 26, 2024 | 2.30M | 15.00% |
Feb 23, 2024 | 2.00M | -4.76% |
Feb 22, 2024 | 2.10M | 16.67% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Catheter Precision | 3.65M |
Onconetix | 3.63M |
Innovative Eyewear | 3.62M |
Zhongchao | 3.59M |
Assure Holdings | 3.59M |
TC Biopharm (Holdings) | 3.45M |
Kintara Therapeutics | 3.44M |
Petros Pharmaceuticals | 3.41M |